Drilldown: Medicines
Appearance
Medicines > routes
:
Intravenous (continuous infusion in a REMS-certified facility)
or
Topical ophthalmic
& onset:
Postprandial glucose effect within days; HbA1c by 12 weeks 
:
Intravenous (continuous infusion in a REMS-certified facility)
or
Topical ophthalmic
& onset:
Postprandial glucose effect within days; HbA1c by 12 weeks 
Use the filters below to narrow your results.
There are no results for this report.

